Rifampicin allergy confirmed by an intradermal test, but with a negative patch test.
Strauss
R M
RM
Department of Dermatology, Royal Hallamshire Hospital, Sheffield, UK.
Green
S T
ST
Gawkrodger
D J
DJ
D000995:Antitubercular Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003937:Diagnosis, Differential; D003875:Drug Eruptions / Q000175:diagnosis* / Q000209:etiology; D004977:Ethambutol / Q000008:administration & dosage; D005188:False Negative Reactions; D005260:Female; D006801:Humans; D007428:Intradermal Tests; D007538:Isoniazid / Q000008:administration & dosage; D008875:Middle Aged; D010328:Patch Tests; D014395:Peritonitis, Tuberculous / Q000188:drug therapy*; D011718:Pyrazinamide / Q000008:administration & dosage; D011736:Pyridoxine / Q000008:administration & dosage; D012293:Rifampin / Q000008:administration & dosage / Q000009:adverse effects*
D000995:Antitubercular Agents; D011718:Pyrazinamide; D004977:Ethambutol; D011736:Pyridoxine; D007538:Isoniazid; D012293:Rifampin